1. Introduction {#Section1}
===============

Premature senescence of human dermal fibroblasts can be induced by exposures to a variety of oxidative stress and DNA damaging agents. Debacq-Chainiaux F. et al. developed a robust model of UVB-induced premature senescence of human dermal fibroblasts (UVB-SIPS)[@B1]. This model represents an alternative *in vitro* model in photoaging research for investigating photoaging-related mechanisms[@B2].

MicroRNAs (miRNAs) have emerged recently as a new class of small evolutionarily conserved non-coding RNAs that negatively regulate gene expression. Several miRNAs have been shown to be involved in the regulation of pathways involved in SIPS and response to ultraviolet irradiation[@B3], [@B4]. MiR-34c-5p has been reported to mediate growth arrest and upregulation of the percentage of aging cells in a variety of cell types[@B5]. Kyle Lafferty-Whyte et al. also reviewed that miR-34c had the potential to regulate all 4 kinds of senescence induction types (replicative senescence, oxidative stress, oncogene expression, and DNA damage signaling). Their study highlights future potential of miR-34c as novel drug targets for senescence induction[@B6].

Two mature miRNA species are derived from the miR-34c precursor, namely miR-34c-5p and miR-34c-3p. However, they have different seed sequences that regulate different targets. In the present study, we found that miR-34c-5p was overexpressed in UVB-SIPS fibroblasts by means of miRNA microarray, and further confirmed by real-time quantitative PCR (qRT-PCR). In consideration of the functions of miR-34c mentioned above, we speculate that miR-34c-5p might play very important roles in cellular senescence, which needs further study.

2. Experimental Section {#Section2}
=======================

Cultivation of primary human dermal fibroblasts and UV light source
-------------------------------------------------------------------

Primary human dermal fibroblasts were obtained from four Chinese donors aged 8-12 years by means of a foreskin circumcision, and cells were cultured by the same method previously used [@B7]. For the experiments, human dermal fibroblasts used were between passage 2-4. The source of UVB was BLE-1T158 (Spectronics Corp., Westbury, NY, USA). A Kodacel filter (TA401/407, Kodak, Rochester, USA) was used to block wavelengths of less than 290 nm (ultraviolet C). The UVB dosage was quantified using a Waldmann UV meter (model no. 585100: Waldmann Co., VS-Schwenningen, Germany).

Induction of UVB-SIPS and SA-β-gal activity detection
-----------------------------------------------------

25mJ/cm^2^UVB was performed twice a day for 5 days. Control cells were kept in the same culture conditions without UVB exposure. At 48 hours after the last stress, the SA-β-gal activity was assessed with SA-β-gal Staining kit (Biotime, Haimen, China) by using the method originally described by Oh et al[@B8].

RNA isolation and miRNA microarray
----------------------------------

Total RNA isolation and miRNA enrichment were performed with a mirVana miRNA Isolation Kit (Ambion, Austin, TX, USA) according to the manufacturer\'s instructions. RNA concentration was quantified with a NanoDrop spectrophotometer (Thermo Fisher, Waltham, MA, USA). RNA integrity was evaluated using an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). RNA labeling and hybridization on the Agilent miRNA microarray chips were performed with an miRNA Labeling Reagent and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) at 37 °C for 30 min.

Each total RNA sample (100 ng) was treated with calf intestine alkaline phosphatase (TaKaRa, Dalian, China), denatured using 100% dimethyl sulfoxide (Sigma, Taufkirchen, Germany) at 100 °C for 8 min in a thermal cycler, and then transferred to an ice-water bath to prevent RNA from re-annealing. The RNA samples were then labeled with pCp-Cy3 using T4 RNA ligase (Ambion, Austin, TX, USA) via incubation at 16 °C for 2 h. The labeled samples were hybridized to Agilent human miRNA microarrays, which contained probes for 1223 miRNAs cataloged in the Sanger Cambridge database v10.1 (<http://microrna.sanger.ac.uk>). Hybridizations were performed in SureHyb chambers (Agilent Technologies, Santa Clara, CA, USA) for 24 h at 55 °C. The microarrays were then washed using Agilent-prepared buffers.

The microarray images were scanned with an Agilent microarray scanner, gridded, and analyzed using Agilent Feature Extraction Software version 9.5.1 (Santa, Clara, CA, USA). Normalization was performed using the per-chip median normalization method and the median array [@B9].

Reverse-transcription real-time PCR analysis
--------------------------------------------

Expression of individual miRNAs was detected by qRT-PCR using miRNA sequence-specific primers (Applied Biosystems, Foster City, CA). Briefly, 10 ng of total RNA was reverse-transcribed using a High-Capacity cDNA Archive kit (Applied Biosystems) followed by amplification in an ABI 7500 Real-Time PCR System (Applied Biosystems, Santa Clara, CA, USA). All RT-PCRs were performed in triplicate. The small nucleolar RNA U6 was used as an endogenous control for the normalization of RNA input. MiRNA expression levels were calculated by relative quantification using ABI 7500 Real-Time PCR SDS 1.2 software (Applied Biosystems, Santa Clara, CA, USA), and the fold change of expression \|log~2~(**Control / UVB-SIPS**)\| ≥ 2 were considered as significantly changes. The PCR reaction without template served as a negative control.

Design and subcloning of short hairpin siRNA template into lentiviral vector
----------------------------------------------------------------------------

A third generation of self-inactivating lentivirus vector containing a CMV-driven GFP reporter and a H1 promoter upstream of cloning restriction sites (ClaI and mluI) to allow the introduction of oligonucleotides encoding short hairpin RNAs (shRNAs) was provided by Genechem (Shanghai, China). The hairpin consists of a T, a 21 nt sense sequence, a short spacer (TTCAAGAGA), an antisense sequence, 6 Ts (a stop signal for RNA polymerase III) and an mluI site. Oligos were annealed and inserted between the mluI and ClaI sites of the plasmid. The shDNA sequence for constructing lentiviruses against human pre-miR-34c-5p (Lenti-siR-miR-34c-5p) was 5′- AGGCAGUGUAGUUAGCUGAUUGC-3′ and 5′- AAUCACUAACCACACGGCCAGG-3\'. Correct insertions of shRNA cassettes were confirmed by restriction mapping and direct DNA sequencing.

Lentivirus production
---------------------

Recombinant lentiviruses were produced by co-transfecting 293T cells with the lentivirus expression plasmid and packaging plasmids using calciumphosphate method. Infectious lentiviruses were harvested at 48 and 72 h post transfection, centrifuged to eliminate cell debris, and then filtered through 0.22-μm cellulose acetate filters. Infectious titer was determined by fluorescence-activated cell sorting analysis of green fluorescent protein (GFP) positive in 293T cells. Virus titers were in the range of 10^8^ transducing units/mL medium.

Lentiviral vector transductions
-------------------------------

On the day of transduction, NHSFs were replated at 2×10^4^ cells/well in 12-well plates along with recombinant lentivirus Lenti-siR-miR-34c-5p at different multiplicities of infection (MOIs) in serum-free growth medium containing 5 mg/mL polybrene at 37 °C and 5% CO~2~. After 4 h, serum containing growth medium was added to the cells, and there was complete replacement of growth medium after 48 h. GFP expression was examined by fluorescent microscopy after 8 days. NHSFs were plated in six-well plates at a density of 1×10^5^ cells per well and transfected with Lenti-siR-miR-34c-5p at an MOI of 100 as described above. Empty virus vector control plasmids was employed as vector control and equal volume saline as negative control.

Assay for E2F3 over-expression
------------------------------

Eukaryote pIRES-E2F3 expression vector was generated by inserting the open reading frame of E2F3a cDNA into the Cla I/EcoR I site of the pIRES1 neo vector (Clontech Laboratories, Inc., Mountain View, CA, USA). Fibroblasts were seeded into 6-well plates at a concentration of 0.5×10^5^/well and transfected with 0.5 μg/well of pIRES1 neo as a control vector or pIRES-E2F3 expression vector by using Lipofectamine RNAiMAX. The effects manifested by E2F3 over-expression were assayed at 7 days after the transfection with plasmids.

Cell cycle detection
--------------------

Fibroblasts were fixed with 70% alcohol, washed twice with PBS, digested with RNase, and stained with propidium iodide (PI). A flow cytometer (FAC-Scan, BD, NJ, USA) was used to gather data and images, to analyze the cell cycle, and to calculate the percentage of cells in the G1 phase.

Bioinformatic analysis of miR-34c-5p target genes
-------------------------------------------------

Putative miR-34c-5p targets were predicted using several different algorithms, including TargetScan (<http://www.targetscan.org/>), Pictar (<http://pictar.bio.nyu.edu/>) and miRanda (<http://microrna.sanger.ac.uk/>). An interaction between miR-34c-5p and the 3\' UTR of its target gene was predicted by RNAhybrid (<http://bibiserv.techfak.uni-bielefeld.de/rnahybrid/>).

Dual-luciferase assay
---------------------

The 3\' UTR of human E2F3, with one predicted miR-34c-5p binding site mutations (2730-2737, Figure [4](#F4){ref-type="fig"}), was inserted into the multicloning site of the pMir-Luc-target vector plasmid (Shanghai Bioladder Co., Ltd, Shanghai, China). The miR-34c-5p expression clone (miR-34c-5p) was constructed downstream a CMV promoter, and a luciferase assay was performed (Luc-Pair miR Luciferase Assay Kit; GeneCopoeia). The cells were plated in six wells and incubated until 70% confluent and transfected with one of the following 6 combinations: (1) E2F3 3\' UTR (2730-2737); (2) E2F3 3\' UTR with miR-34c-5p 2730-2737 seed-matching mutation (E2F3 3\' UTR (2730-2737) mt); (3) E2F3 3\' UTR (2730-2737) + sc-miR (miRNA scramble control); (4) E2F3 3\' UTR (2730-2737) mt + sc-miR; (5) E2F3 3\' UTR (2730-2737) + miR-34c-5p; (6) E2F3 3\' UTR (2730-2737) mt + miR-34c-5p. The cells were transferred to a 96-well plate 18 hours after transfection and cultured for another 24 h. Both firefly luciferase and Renilla luciferase activities were determined in the NHSFs. Firefly luciferase activity was then normalized with Renilla luciferase activity in the same well.

Detection of E2F3, P21^WAF-1^, and P53 expression
-------------------------------------------------

The primer sequence and size of PCR products of target genes are listed in Table [1](#T1){ref-type="table"}. U6 primers were used as internal RNA loading and amplification controls. Primary antibodies against E2F3 (Santa Cruz Biotechnology, Santa Cruz, CA), p21^WAF-1^ (Cell Signaling Technology, California, USA), P53 (Cell Signaling Technology, California, USA), and β-actin (Biotime, Haimen, China) were used in western blot analysis.

Statistical analysis
--------------------

All analyses were performed with SPSS 13.0 (SPSS Corporation, Chicago, CA, USA). Statistical significance of multiple treatments was determined by analysis of variance (ANOVA) test. P \<0.05 was considered to be significant.

3. Results and Discussion {#Section3}
=========================

In order to screen the differentially expressed miRNA in UVB-SIPS, we compared the miRNA expression pattern in UVB-SIPS with untreated control in dermal fibroblast. In total, 8 miRNAs were up-regulated and 5 miRNAs were down-regulated after a total of 250 mJ/cm^2^ UVB irradiation at 48 hours after last irradiation (Table [2](#T2){ref-type="table"}).

MiR-34c-5p expression was further confirmed to be increased significantly (P \< 0.05) after UVB treatment by qRT-PCR detection (Figure [1](#F1){ref-type="fig"}). Then, we transfected Lenti-siR-miR-34c-5p or Empty Virus Vector into fibroblasts and named them as fibroblasts-siR-miR-34c-5p and fibroblasts-vector, respectively. We used qRT-PCR to confirm the expression level of miR-34c-5p (Figure [2](#F2){ref-type="fig"}).

To explore the role of miR-34c-5p in cellular senescence induced by UVB, fibroblasts-vector and fibroblasts-siR-miR-34c-5p were treated with repeated UVB treatments. As expected, after treatment, fibroblasts-vector irradiated cells became enlarged and irregular in shape, and the percentage of SA-β-gal positive cells increased (Figure [3](#F3){ref-type="fig"}b; P \< 0.05. fibroblasts-vector: 8.03±1.32%, fibroblasts-vector+UVB-SIPS: 90.83±2.92%). However, underexpression of miR-34c-5p alleviated the morphological changes induced by repeated UVB treatments (Figure [3](#F3){ref-type="fig"}a). There were less SA-β-gal positive cells in fibroblasts-siR-miR-34c-5p than that in fibroblasts-vector after UVB treatment (Figure [3](#F3){ref-type="fig"}b; P \< 0.05. fibroblasts-siR-miR-34c-5p+UVB-SIPS: 36.88±5.53%). Our data provided evidence that the down-regulation of miR-34c-5p in human dermal fibroblasts can delay UVB-induced premature senescence. In good agreement with our report, Kumamoto et al. showed that after the administration of the MDM2 inhibitor, Nutlin-3, to human diploid fibroblasts, induction of miR-34c as well as senescence was observed[@B10].

To assess whether the over-expression of miR-34c-5p affects the G1 arrest in fibroblasts after UVB-SIPS, the percentage of cells in G1 phase were measured. The level of G1 phase was increased in fibroblasts-vector+UVB-SIPS. However, down expression of miR-34c-5p antagonized the above change (Figure [3](#F3){ref-type="fig"}c).

Compared with classical transcriptional factors, miRNAs act mainly via regulation of their target genes at the mRNA level. For example, regulation of microtubule-associated protein tau by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel [@B11]. miR-34c-5p directly targets sGCbeta under hypoxia [@B12]. Gluconeogenesis is severely compromised in hepatocellular carcinoma (HCC) by IL6-Stat3-mediated activation of miR-23a, which directly targets PGC-1α and G6PC, leading to decreased glucose production [@B13]. With the help of current bioinformatics software, we proposed that E2F3, which play an essential role in cell cycle progression, proliferation, and development, is the target of miR-34c-5p. Moreover, dual-luciferase assay analysis indicated that the predicted 2730-2737 binding site was functional *in vitro*(Figure [4](#F4){ref-type="fig"}). To further confirm the effect of miR-34c-5p on E2F3 expression, we detected the mRNA and protein levels of E2F3 under miR-34c-5p down-expression condition after UVB-SIPS. We found that the expression of E2F3 decreased significantly in UVB-SIPS and then they were rescued by miR-34c-5p down-expression in fibroblasts-siR-miR-34c-5p after repeated UVB treatments (Figure [5](#F5){ref-type="fig"}; P \< 0.05). These results indicated that E2F3 is a real down-stream target of miR-34c-5p.

It is reported that activation of the p53 pathway could be caused as a consequence of the repression of the E2F3 as in the case of fibroblast with knockout of E2F3 [@B14]-[@B16]. It is well-established that the p53 pathway is involved in aging and photoaging [@B17]. Active p53 is known to trigger p21^WAF-1^ overexpression [@B18]. P21^WAF-1^ is a cyclin dependent kinase inhibitor that blocks the cell cycle in G1 phase [@B19], which corresponds to the cell cycle analysis results. Supporting these assumptions, we confirmed that UVB-SIPS increased the expression of p21^WAF-1^ and P53 expression in cultured fibroblasts. To further investigate the mechanism of miR-34c-5p in UVB-induced senescence, we explored the effects of miR-34c-5p on p21^WAF-1^ and P53 expression in UVB-SIPS fibroblasts. We found that the expression of p21^WAF-1^ and P53 were decreased by miR-34c-5p under-expression in fibroblasts-siR-miR-34c-5p after repeated UVB treatments (Figure [5](#F5){ref-type="fig"}; P \< 0.05). Moreover, over-expressed E2F3, which is confirmed to be the direct target of miR-34c-5p, can rescue fibroblasts from UVB induced premature senescence. As indicated by our results, there were less SA-β-gal positive cells in pIRES-E2F3 than that in pIRES1-vector after UVB treatment (Figure [6](#F6){ref-type="fig"}c; P \< 0.05, UVB-SIPS+pIRES-E2F3: 54.82±4.55%). In light of our results, it seems reasonable to conclude that decreased levels of miR-34c-5p may contribute to up-regulated E2F3 which sequentially lead to inactivation of p53-p21 pathway thus interfering with UVB-SIPS induced senescence. It has been shown that active p53 directly induces miR-34c-5p expression [@B20], [@B21]. In this consideration, miR-34c-5p in turn indirectly increases p53 activity, thus establishing a positive feedback loop leading to cell-cycle arrest. However, additional experiments will be required to confirm this interpretation.

The major damage of photoaged skin is related to the connective tissue of the dermal compartment with quantitative and qualitative alterations of the dermal extracellular matrix [@B22]. It has been reported that following chronic ultraviolet stress treatment, the expression of interstitial collagenase/matrix metalloproteinase-1 is induced. This induction is prolonged in the period of growth arrest phase in dermal fibroblasts, while tissue inhibitor of metalloproteinase-1, the major inhibitor of matrix-metalloproteinase-1, is only slightly induced [@B23]. This imbalance between matrix-degrading metalloproteinases and their inhibitors may lead to connective tissue damage, a hallmark of premature aging. These findings, together with our observation that miR-34c-5p plays an important role in cellular senescence, suggesting that miR-34c-5p may also be involved in photoaging of the skin.

4. Conclusions {#Section4}
==============

We found that several miRNAs, including miR-34c-5p, are dysregulated in UVB-SIPS, and down-regulation of miR-34c-5p can delay senescence of human dermal fibroblasts induced by UVB treatment. Further study elucidate that E2F3 is the downstream target of miR-34c-5p. E2F3 regulated P53-P21 pathway play a role in regulating the procedure of UVB-SIPS. We believe that the relationships of miR-34c-5p and some senescence-related proteins, and the exact mechanisms of miR-34c-5p in senescence might be a novel and potent way to study cellular senescence and photoaging.
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![**qRT-PCR confirmation of miR-34c-5p expression in UVB-induced premature senescence of human dermal fibroblasts**. Results are shown as means±SD (n = 3). \*P\<0.05 compared with control group. Bars, mean ± standard error.](ijbsv09p0743g01){#F1}

![**Determination of lentiviral transduction efficiency and lentivirus-mediated miR-34c-5p down-expression in fibroblasts**. (A) Transduction efficiency was estimated 8 days after infecting at indicated MOIs. GFP expression was observed under light microscopy (up), fluorescence microscopy (down). The highest GFP expression of NHSFs appeared with MOI of 100. (B) MiR-34c-5p was underexpressed by lentivirus transfection in dermal fibroblasts and confirmed by qRT-PCR. Results are shown as means±SD (n = 3).](ijbsv09p0743g02){#F2}

###### 

**MiRNA underexpression delayed premature senescence induced by repeated subcytotoxic UVB treatments in normal human dermal fibroblasts**. (a) The SA-β-gal staining in fibroblasts-vector and fibroblasts-siR-miR-34c-5p after repeated UVB treatments. (b) The SA-β-gal positive cells were increased significantly in non-transfected and fibroblasts-vector after repeated UVB treatments, and there were less SA-β-gal positive cells in fibroblasts-siR-miR-34c-5p than that in fibroblasts-vector after repeated UVB treatments. Results are shown as means±SD (n = 3). (c) The G1 phase cells were increased significantly in non-transfected and fibroblasts-vector after repeated UVB treatments, and there were less G1 phase cells in fibroblasts-siR-miR-34c-5p than that in fibroblasts-vector after repeated UVB treatments. Results are shown as means±SD (n = 3). \*P \< 0.05, compared with UVB-SIPS and UVB-SIPS+fibroblasts-vector.
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![**MiR-34c-5p targets the E2F3 3\' UTR.**Mutation of a predicted miR-34c-5p binding site in the E2F3 3\' UTR (2730-2737) abrogated the repressive effect of miR-34c-5p on the luciferase activity of a E2F3 3\' UTR-luciferase reporter. Results are shown as means±SD (n = 3). \*P \< 0.05 versus wild type.](ijbsv09p0743g06){#F4}

###### 

**Effect of miR-34c-5p downexpression on E2F3, p21^WAF-1^ and P53 expression in UVB-SIPS fibroblasts**. (a) qRT-PCR analysis of E2F3, p21^WAF-1^ and P53 in control, UVB-SIPS, fibroblasts-siR-miR-34c-5p and UVB-SIPS+ fibroblasts-siR-miR-34c-5p. Results are shown as means±SD (n = 3). (b) Western blotting analysis of E2F3, p21^WAF-1^ and P53 level in control, UVB-SIPS, fibroblasts-siR-miR-34c-5p and UVB-SIPS+ fibroblasts-siR-miR-34c-5p. (c) Blots from triplicate experiments were scanned, and densitometric values corrected for actin were plotted as mean±SD. \*P \< 0.05, ^\#^P \< 0.05, ^%^P \< 0.05 compared with UVB-SIPS.
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###### 

Enforced expression of E2F3 delayed premature senescence induced by repeated subcytotoxic UVB treatments in normal human dermal fibroblasts. (a) E2F3 was over-expressed by pIRES-E2F3 vector transfection in dermal fibroblasts after repeated UVB treatments and confirmed by qRT-PCR. (b) The SA-β-gal staining in pIRES-E2F3 or pIRES1-vector transfected fibroblasts after repeated UVB treatments. (c) The SA-β-gal positive cells were increased significantly in non-transfected and pIRES1-vector after repeated UVB treatments, and there were less SA-β-gal positive cells in pIRES-E2F3 transfected fibroblasts than that of in pIRES1-vector group after repeated UVB treatments. Results are shown as means±SD (n = 3). ^\#^P \< 0.05, compared with pIRES1-vector and negative control. \*P \< 0.05, compared with UVB-SIPS and UVB-SIPS+pIRES1-vector.
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###### 

The primer sequence of target genes.

  ------------------------------------------------------------------
  Gene name                       primer sequences
  ------------ ------------------ ----------------------------------
  E2F3         Forward primer:\   5\`- CGGTCATCAGTACCTCTCAGA-3\`\
               Reverse primer:    5\`- AGACGTATCATACCGCGTTTTT -3\`

  p53          Forward primer:\   5\`- CCGCAGTCAGATCCTAGCG -3\`\
               Reverse primer:    5\`- AATCATCCATTGCTTGGGACG -3\`

  p21          Forward primer:\   5\`- CCTCATCCACCCCATCCCT -3\`\
               Reverse primer:    5\`- GTCCATAGCCTCTACTGCCA -3\`

  GAPDH        Forward primer:\   5\`-TGTTGCCATCAATGACCCCTT-3\`\
               Reverse primer:    5\`-CTCCACGACGTACTCAGCG -3\`

  MiR-34c-5p   Forward primer:    5\`-AGGCAGTGTAGTTAGCTGATTGC-3\`

  U6           Forward primer:\   5\`-ATTGGAACGATACAGAGAAGATT-3\`\
               Reverse primer:    5\`-GGAACGCTTCACGAATTTG-3\`
  ------------------------------------------------------------------

###### 

Differently expressed miRNAs in UVB-induced premature senescence of human dermal fibroblasts

  miRNAs              Normalization   log~2~ (Control / UVB-SIPS)   
  ------------------- --------------- ----------------------------- -----------
  hsa-miR-1224-3p     419.357776      1692.797989                   2.013156
  hsa-miR-197-3p      2149.208603     10773.654995                  2.32563
  hsa-miR-1976        1103.044789     4707.197797                   2.093377
  hsa-miR-23a-5p      1033.895368     4379.935474                   2.082819
  hsa-miR-34c-5p      639.074483      2801.90345                    2.132351
  hsa-miR-4701-5p     658.034808      3367.663795                   2.355512
  hsa-miR-574-5p      327.902091      1370.018711                   2.062859
  hsa-miR-766-3p      1964.066606     8691.728655                   2.145799
  hsa-miR-1185-1-3p   1599.359178     311.123359                    -2.361935
  hsa-miR-1185-2-3p   1502.326927     262.706468                    -2.515675
  hsa-miR-4638-5p     1734.31208      375.679215                    -2.20679
  hsa-miR-4695-5p     5210.743432     979.097142                    -2.411965
  hsa-miR-933         9073.073163     1658.726843                   -2.451515
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